Sphere-9 Catheter Adverse Events: FDA MAUDE Data

MEDTRONIC, INC. · Cardiac Ablation Catheter for Atrial Flutter, Cardiac Ablation Catheter for Atrial Fibrillation, Cardiac Ablation Catheter (Pulsed Field/PFA) · First cleared Oct 2024 · 3 device variants grouped

Total Reports

1,011

Reports (30d)

108

Active Signals

1

Open Recalls

2

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

High Temperature Sensor Error

ventricular, sphere catheter, error, result event, sphere

56

reports

2

Impedance Increase During RF Application

cavotricuspid isthmus, sphere catheter, outcome case, intracardiac echocardiography, radiofrequency

14

reports

3

Asymptomatic Cerebral Infarction Detected

day, cerebral, infarction, imaging, result event

13

reports

4

Substance on Catheter Handle

substance, procedure catheter, tip, resistance, outcome case

12

reports

5

Ventricular Tachycardia Induced by Ablation

cavotricuspid isthmus, ventricular, cavotricuspid, radiofrequency, result event

10

reports

6

Coronary Spasm with ST Elevation

varipulse, spasm, event cardiac, elevation, result event

10

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Active safety signals

Changepointcritical

FDA recalls for this device

Class II

Mar 11, 2026 · Open, Classified

ventricular fibrillation (VF) during radiofrequency (RF) therapy with the Medtronic Sphere-9 catheter in patients who have a Biotronik Implantable Cardioverter Defibrillator (ICD) or Biotronik Cardiac Resynchronization Therapy-Defibrillator (CRT-D) implanted. The observation is caused by an interaction between the Sphere-9 catheter current flow and a safety feature built into Biotronik ICDs and CRT Ds. Medtronic recommends physicians use increased caution when using the Sphere-9 catheter for RF ablation therapy in patients implanted with a Biotronik ICD/CRT-D system, and to ensure external defibrillation systems are readily available.

Class III

Mar 4, 2019 · Open, Classified

The firm issued an updated instructions for use to reduce the potential for phrenic nerve injury.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 1 active signal detected right now.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.